The impact of comorbid disorders on adults with ADHD

Psychiatric Times

Volumn 24, Issue SUPPL. 2, 2007, Pages 7-10

  Baron, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34548714039     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Faraone SV, Biederman J. Neurobiology of ADHD. Biol Psychiatry. 1998;44(10):951-958.
2. Report from the third international meeting of the Attention-Deficit Hyperactivity Disorder Molecular Genetics Network. Am J Med Genet. 2002;114(3):272-276.
3. Still GF. Some abnormal psychical conditions in children: the Goulstonian lectures. Lancet. 1902;1:1008-1012.
4. Laufer MW, Denhoff E. Hyperkinetic behavior syndrome in children. J Pediatr. 1957;50(4):463-474.
5. Wood DR, Reimherr FW, Wender PH, Johnson GE. Diagnosis and treatment of minimal brain dysfunction in adults: a preliminary report. Arch Gen Psychiatry. 1976;33(12):1453-1460.
6. Spencer T, Wilens T, Biederman J et al. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry. 1995;52(6):434-443.
7. Wilens TE, Spencer TJ, Biederman J et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry. 2001;158(2):282-288.
8. O'Donnell JP, McCann KK, Pluth S. Assessing adult ADHD using a self-report symptom checklist. Psychol Rep. 2001;88(3 pt 1):871-881.
9. Kessler RC, Adler L, Ames M et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256 [see comment].
10. Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales: Technical Manual. New York: Multi-Health Systems; 1999.
11. Kessler RC, Adler L, Barkley R et al. The prevalence of correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-723 [see comment].
12. Biederman, Faraone SV. Attention-deficit hyperactivity disorder. [Published erratum in Lancet. 2006;367(9506):210.] Lancet. 2005;366(9481):237-248.
13. Nierenberg AA. Improved outcomes in the diagnosis and treatment of depression and comorbid ADHD. ADHD Practice Guide. 2006;1(4):1-10.
14. Wilson JJ. ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment. Am J Addict. 2007;16(suppl 1):5-11.
15. Lambert NM, Hartsough CS. Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil. 1998;31(6):533-544 [see comment].
16. Baron DA, Bizamcer AN. The relationship of ADHD, its treatment, and substance use. Behavioral Health Management. 2004;24(4):S1-S4.
17. Pliszka SR. Non-stimulant treatment of ADHD. CNS Spectr. 2003;8(4):253-258.
18. Maidment ID. The use of antidepressants to treat attention deficit hyperactivity disorder in adults. J Psychopharmacol. 2003;17(3):332-336.
19. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity in adults. CMAJ. 2003;168(6):715-722 [see comment].
20. Young JL. ADHD: Grown Up: A Guide to Adolescent and Adult ADHD. New York: WW Norton; 2007.